SPECTRACURE AB
Research SPECTRACURE AB (2OK) on Bullrun: market cap EUR 73.55K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2OK
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 73.55K
- Financial periodQ1 2026
- RevenueSEK 0
- Net income-SEK 6.14M
- Free cash flow-SEK 9.33M
Valuation Snapshot
latest market cap is EUR 73.55K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 0 | -SEK 56.08M | -SEK 43.67M | n/a | -0.21 | SEK 13.53M | SEK 2.79M | SEK 93.55M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 73.55K | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About SPECTRACURE AB
SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SPECTRACURE AB's market cap?
SPECTRACURE AB's market capitalization is EUR 73.55K.
What does SPECTRACURE AB do?
SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden.